APT Medical's (SHA:688617) net profit attributable to shareholders in 2024 rose 26% to 673.2 million yuan from 533.9 million yuan a year earlier, according to a Wednesday filing with the Shanghai Stock Exchange.

Earnings per share climbed 27% year on year to 6.92 yuan from 5.46 yuan.

The Chinese medical device company's operating income in the same period inched 25% higher to 2.07 billion yuan from 1.65 billion yuan in the previous year, the filing said.

The company's shares dropped 4% in recent trade.